Law firm investigates Amylyx Pharmaceuticals officers for possible shareholder duty breaches

Halper Sadeh LLC is investigating whether certain officers and directors of Amylyx Pharmaceuticals breached their fiduciary duties to shareholders. Long-term Amylyx stockholders may seek corporate governance reforms, financial incentives, or other relief. The firm offers free consultations and works on a contingent fee basis, urging shareholders to act quickly due to potential time limits. This investigation could lead to improved company oversight and possible compensation for investors if breaches are confirmed.